In 2008, Braasch Biotech LLC was incorporated in the State of South Dakota.
In addition to developing and testing its Somatostatin vaccine technology in a variety of species and for different metabolic conditions, the company has also expanded its worldwide intellectual property positions by multiple filings and anticipates several additional filings to support their technology [REF].